To broaden its market access in China, Pfizer Inc. partnered with a military-linked Chinese pharmaceutical firm, The National Pulse can reveal.
Pfizer signed a memorandum of understanding with Shanghai Pharmaceutical Co. Ltd. in April of 2011, which set up "For the companies to jointly pursue potential business opportunities in China."
"The potential partnership is intended to leverage both companies' strengths," explained a company press release, adding the deal would be "Matching Pfizer's global capabilities in developing innovative medicines with Shanghai Pharmaceutical's capabilities and reach in the China market."
Shanghai Pharmaceuticals has supported the "Military combat" efforts of China's People's Liberation Army and partnered with universities funded by the PLA. These unearthed links exacerbate the fact that the company is subject to Article 7 of China's National Intelligence Law, which mandates that "Any [Chinese] organization or citizen shall support, assist, and cooperate with state intelligence work."
Since 2007, the Company has begun to organize and implement drug storage on behalf of the military combat.
In addition to its agreement with Pfizer, Shanghai Pharmaceuticals has also partnered with China's Secondary Military Medical University, also known as the People's Liberation Army Naval Medical University.
Pfizer's newfound partnership with the Chinese military-linked entity follows The National Pulse unearthing the pharmaceutical giant's collaborations with China's "Vaccine passport" platform in 2018.
https://thenationalpulse.com/2022/02/21/pfizer-partnered-with-arm-of-chinas-military/
No comments:
Post a Comment